Future directions in malignant hyperthermia research and patient care

Sharon J. Hirshey Dirksen, Marilyn Green Larach, Henry Rosenberg, Barbara W. Brandom, Jerome Parness, Robert Scott Lang, Meera Gangadharan, Tyler Pezalski

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

Malignant hyperthermia (MH) is a complex pharmacogenetic disorder of muscle metabolism. To more closely examine the complexities of MH and other related muscle disorders, the Malignant Hyperthermia Association of the United States (MHAUS) recently sponsored a scientific conference at which an interdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care.

Original languageEnglish (US)
Pages (from-to)1108-1119
Number of pages12
JournalAnesthesia and analgesia
Volume113
Issue number5
DOIs
StatePublished - Nov 2011

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Future directions in malignant hyperthermia research and patient care'. Together they form a unique fingerprint.

  • Cite this

    Hirshey Dirksen, S. J., Larach, M. G., Rosenberg, H., Brandom, B. W., Parness, J., Lang, R. S., Gangadharan, M., & Pezalski, T. (2011). Future directions in malignant hyperthermia research and patient care. Anesthesia and analgesia, 113(5), 1108-1119. https://doi.org/10.1213/ANE.0b013e318222af2e